Literature DB >> 3147831

What happens to patients with rheumatoid arthritis? The long-term outcome of treatment.

T D Spector1, D L Scott.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3147831     DOI： 10.1007/bf02239187

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  147 in total

1.  COURSE AND PROGNOSIS IN RHEUMATOID ARTHRITIS. A FURTHER REPORT.

Authors:  J J DUTHIE; P E BROWN; L H TRUELOVE; F D BARAGAR; A J LAWRIE
Journal:  Ann Rheum Dis       Date:  1964-05       Impact factor: 19.103

2.  Differential inhibition of prostacyclin production and platelet aggregation by aspirin.

Authors:  G Masotti; G Galanti; L Poggesi; R Abbate; G G Neri Serneri
Journal:  Lancet       Date:  1979-12-08       Impact factor: 79.321

3.  Methods of X-ray assessment in rheumatoid arthritis: a re-evaluation.

Authors:  D L Scott; B L Coulton; P A Bacon; A J Popert
Journal:  Br J Rheumatol       Date:  1985-02

4.  A human model screening system for the detection of specific antirheumatic activity.

Authors:  J S Dixon; H A Bird; M E Pickup; V Wright
Journal:  Semin Arthritis Rheum       Date:  1982-11       Impact factor: 5.532

Review 5.  Does drug therapy slow radiographic deterioration in rheumatoid arthritis?

Authors:  L Iannuzzi; N Dawson; N Zein; I Kushner
Journal:  N Engl J Med       Date:  1983-10-27       Impact factor: 91.245

6.  The clinical assessment of joint inflammatory activity in rheumatoid arthritis related to radiological progression.

Authors:  A Young; M Corbett; A Brook
Journal:  Rheumatol Rehabil       Date:  1980-02

7.  C-reactive protein fifty years on.

Authors:  M B Pepys
Journal:  Lancet       Date:  1981-03-21       Impact factor: 79.321

8.  Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes.

Authors:  R S Amos; T J Constable; R A Crockson; A P Crockson; B McConkey
Journal:  Br Med J       Date:  1977-01-22

Review 9.  X-ray assessment of activity in rheumatoid disease.

Authors:  J C Buckland-Wright
Journal:  Br J Rheumatol       Date:  1983-02

10.  The long-term effects of treating rheumatoid arthritis.

Authors:  D L Scott; B L Coulton; J H Chapman; P A Bacon; A J Popert
Journal:  J R Coll Physicians Lond       Date:  1983-01
View more
  9 in total

1.  Arthritis in inner city general practices.

Authors:  E Treasure; D L Scott; P M Katona; P Toon
Journal:  Br J Gen Pract       Date:  1990-02       Impact factor: 5.386

Review 2.  Measuring performance in clinical rheumatology.

Authors:  D L Scott; I Haslock
Journal:  Ann Rheum Dis       Date:  1990-01       Impact factor: 19.103

Review 3.  Combination chemotherapy in rheumatoid arthritis.

Authors:  P M Brooks; A C Schwarzer
Journal:  Ann Rheum Dis       Date:  1991-07       Impact factor: 19.103

Review 4.  Assessment of quality of life in rheumatoid arthritis: methods and implications.

Authors:  P Bendtsen; I Akerlind; J O Hörnquist
Journal:  Pharmacoeconomics       Date:  1994-04       Impact factor: 4.981

5.  Treatment perspectives in rheumatoid arthritis: a descriptive study in a Swedish healthcare district.

Authors:  P Bendtsen; P Bjurulf; E Trell; F Lindström; J E Larsson
Journal:  Pharmacoeconomics       Date:  1994-05       Impact factor: 4.981

6.  Prevalence of chronic arthritis in four geographical areas of the Scottish Highlands.

Authors:  M M Steven
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

Review 7.  Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept.

Authors:  Roy Fleischmann; Imran Iqbal; Pallavi Nandeshwar; Andres Quiceno
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 8.  Pharmacological intervention in older patients with rheumatoid arthritis. Quality of life aspects.

Authors:  P Bendtsen; I Akerlind; J O Hörnquist
Journal:  Drugs Aging       Date:  1995-11       Impact factor: 3.923

9.  Methotrexate in rheumatoid arthritis is frequently effective, even if re-employed after a previous failure.

Authors:  Theresa Kapral; Tanja Stamm; Klaus P Machold; Karin Montag; Josef S Smolen; Daniel Aletaha
Journal:  Arthritis Res Ther       Date:  2006-02-24       Impact factor: 5.156
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.